BLO.CN - Cannabix Technologies Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
2.54
+0.34 (+15.45%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close2.20
Open2.40
Bid2.53 x 0
Ask2.54 x 0
Day's Range2.28 - 2.54
52 Week Range0.51 - 4.18
Volume3,898,622
Avg. Volume512,216
Market Cap244.453M
Beta4.18
PE Ratio (TTM)N/A
EPS (TTM)-0.03
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire7 days ago

    Cannabix Technologies Provides Technology Update on Marijuana Breathalyzer Development

    Cannabix Technologies Inc. (CSE:BLO) (OTC PINK:BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that recent testing with Beta 3.0 has shown the identification and first order separation of two key metabolites of ∆9-tetrahydrocannabinol (“THC”), being 11-hydroxy-delta-9-tetrahydrocannabinol and 11-nor-9-carboxy-tetrahydrocannabinol in standards. ∆9-tetrahydrocannabinol (“THC”) the main psychoactive component of marijuana is metabolized into and 11-nor-9-carboxy-tetrahydrocannabinol at different rates based on route of entry into the body. The Cannabix FAIMS device coupled to real time switchable mass spectrometry is actively being tuned to detect these key molecules and their complex pathways in the body to enable the identification of recency of use.

  • GlobeNewswire20 days ago

    Recent Vermont Legislation Highlights Hurdles Surrounding Cannabis Impairment Testing -- CFN Media

    CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering Cannabix Technologies Inc. (BLO.CN) (BLO.CN) (BLO.CN) (BLOZF)  and the development of its Cannabix Marijuana Breathalyzer that aims to solve the dilemma of cannabis impairment testing with an accurate, non-invasive, portable solution that could be used by law enforcement at roadside. In an effort to bolster public safety amid concerns of cannabis-impaired driving, the state legislature introduced a bill to allow for the use of saliva tests as an alternative to the current system, which requires blood tests, a hospital visit, and a warrant. In a decision that highlights the conundrum public health officials face in regard to cannabis impairment, the Senate Judiciary Committee recently rejected the bill amid concerns of scientific validity, accuracy, and infringement on civil liberties.

  • GlobeNewswire2 months ago

    US and Canadian Officials Scramble to Solve Marijuana-Impaired Driving Issue -- CFN Media

    SEATTLE, April 17, 2018-- CFN Media Group, the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing the complex issues ...

  • GlobeNewswire2 months ago

    Cannabix Technologies Files FAIMS Cannabis Detection Patent - Enters into License Agreement with University of Florida and Provides Technology Update

    VANCOUVER, British Columbia, April 16, 2018-- Cannabix Technologies Inc. developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report it has filed a Patent ...